CH4893237, a novel orally available pure estrogen receptor antagonist downregulates the ER level and inhibits the growth of tamoxifen-sensitive and -resistant breast cancer xenografts.
BREAST CANCER RESEARCH AND TREATMENT（2004）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要